| C00220 |
Methylene blue; Methylthioninium chloride |
(P) unclassified |
| C07055 |
Isopropamide |
(P) unclassified |
| C07506 |
Propantheline |
(P) unclassified |
| C07521 |
Thiopental |
(P) unclassified |
| C07811 |
Hexocyclium |
(P) unclassified |
| C07814 |
Homatropine |
(P) unclassified |
| C07818 |
Mepenzolate |
(P) unclassified |
| C07849 |
Methantheline |
(P) unclassified |
| C07861 |
Tridihexethyl |
(P) unclassified |
| C12768 |
Timepidium bromide; Timepidium bromide anhydrous |
(P) unclassified |
| D00059 |
Levodopa (JP18/USP/INN); Dopar (TN) |
(P) Target: DRD2 |
| D00095 |
Epinephrine (USP/INN); Adrenaline (JP18); Adrenalin (TN); Auvi-q (TN); Epipen (TN) |
(CI,P) unclassified |
| D00113 |
Atropine (USP); Atropen (TN) |
(P) unclassified |
| D00131 |
Disulfiram (JP18/USP/INN); Antabuse (TN) |
(P) CYP inhibition: CYP1A2 |
| D00136 |
Haloperidol (JP18/USP/INN); Haldol (TN) |
(P) Target: DRD2 / CYP inhibition: CYP2D6 |
| D00138 |
Scopolamine (INN); Transderm scop (TN) |
(P) unclassified |
| D00147 |
Hyoscyamine (USP) |
(P) unclassified |
| D00186 |
Ciprofloxacin (JP18/USP/INN); Cipro (TN); Otiprio (TN) |
(P) CYP inhibition: CYP1A2 |
| D00197 |
Reserpine (JP18/USP/INN); Apoplon (TN); Serpalan (TN) |
(P) unclassified |
| D00198 |
Rescinnamine (JAN/INN); Tsuruselpi S (TN) |
(P) unclassified |
| D00210 |
Norfloxacin (JP18/USP/INN); Noroxin (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D00224 |
Allopurinol (JP18/USP/INN); Zyloprim (TN) |
(P) CYP inhibition: CYP1A2 |
| D00232 |
Anisotropine methylbromide (USAN); Octatropine methylbromide (INN); Methyloctatropine bromide (JAN); Valpin (TN); Valpin 50 (TN) |
(P) unclassified |
| D00253 |
Carbidopa hydrate and levodopa; Parcopa (TN); Sinemet (TN) |
(P) unclassified |
| D00270 |
Chlorpromazine (USP/INN); Thorazine (TN) |
(P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D00281 |
Clonidine (JAN/USP/INN); Catarpres-TTS (TN) |
(P) unclassified |
| D00294 |
Diazoxide (JAN/USP/INN); Hyperstat (TN); Proglycem (TN) |
(P) unclassified |
| D00310 |
Enoxacin (USAN/INN); Penetrex (TN) |
(P) CYP inhibition: CYP1A2 |
| D00318 |
Famotidine (JP18/USP/INN); Fluxid (TN); Pepcid (TN) |
(P) CYP inhibition: CYP1A2 |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) unclassified |
| D00397 |
Tropicamide (JP18/USP/INN); Mydriacyl (TN) |
(P) unclassified |
| D00405 |
Methyldopa (USP); Methyldopa hydrate (JP18); Aldomet (TN) |
(P) unclassified |
| D00418 |
Minoxidil (JAN/USP/INN); Loniten (TN); Riup (TN); Rogaine (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP18/USP/INN); Risperdal (TN) |
(P) Target: DRD2 HTR2A / CYP inhibition: CYP2D6 |
| D00430 |
Secobarbital (USP/INN); Seconal (TN) |
(P) unclassified |
| D00465 |
Oxybutynin (USAN/INN); Anturol (TN); Oxytrol (TN) |
(P) unclassified |
| D00474 |
Primidone (JP18/USP/INN); Mysoline (TN) |
(P) unclassified |
| D00481 |
Propantheline bromide (JP18/USP/INN); Pro-banthine (TN) |
(P) unclassified |
| D00499 |
Pentobarbital (USP/INN); Nembutal (TN) |
(P) unclassified |
| D00500 |
Pentobarbital sodium (JAN/USP); Nembutal sodium (TN) |
(P) unclassified |
| D00502 |
Pergolide mesylate (USP); Pergolide mesilate (JAN); Permax (TN) |
(P) Target: DRD2 |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
| D00540 |
Glycopyrrolate (USP); Glycopyrronium bromide (JAN/INN); Cuvposa (TN); Robinul (TN); Seebri breezhaler (TN) |
(P) unclassified |
| D00555 |
Amobarbital (JP18/INN); Isomytal (TN) |
(P) unclassified |
| D00559 |
Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) |
(P) Target: DRD2 |
| D00603 |
Timolol maleate (JP18/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) CYP inhibition: CYP2D6 |
| D00604 |
Clonidine hydrochloride (JP18/USP); Nexiclon (TN); Kapvay (TN); Duraclon (TN); Catapres (TN) |
(P) unclassified |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) unclassified |
| D00608 |
Doxazosin mesylate (USP); Doxazosin mesilate (JP18); Cardura (TN) |
(P) unclassified |
| D00609 |
Prazosin hydrochloride (JP18/USP); Minipress (TN) |
(P) unclassified |
| D00611 |
Mecamylamine hydrochloride (USP); Inversine (TN) |
(P) unclassified |
| D00612 |
Trimetaphan camsilate (JAN/INN); Trimetaphan camsylate; Arfonad (TN) |
(P) unclassified |
| D00613 |
Fenoldopam mesylate (USP); Corlopam (TN) |
(P) unclassified |
| D00614 |
Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN); Nitropress (TN) |
(P) unclassified |
| D00633 |
Dopamine hydrochloride (JP18/USP); Actopamin (TN); Intropin (TN) |
(P) Target: DRD2 |
| D00646 |
Tolterodine (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) CYP inhibition: CYP2D6 |
| D00679 |
Ergotamine tartrate (JP18/USP); Ergomar (TN) |
(P) Target: HTR1A |
| D00698 |
Aprobarbital (INN); Alurate (TN) |
(P) unclassified |
| D00699 |
Butabarbital sodium (USP); Secbutabarbital sodium (INN); Butabarb (TN); Butisol sodium (TN) |
(P) unclassified |
| D00700 |
Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00707 |
Fomepizole (JAN/USAN/INN); Antizol (TN) |
(P) CYP inhibition: CYP1A2 |
| D00712 |
Methohexital sodium (USP); Brevital sodium (TN) |
(P) unclassified |
| D00713 |
Thiamylal sodium (JP18); Surital (TN) |
(P) unclassified |
| D00714 |
Thiopental sodium (JP18/USP/INN); Pentothal (TN) |
(P) unclassified |
| D00715 |
Methscopolamine bromide (USP); Hyoscine methobromide (INN); Pamine (TN) |
(P) unclassified |
| D00716 |
Clidinium bromide (USP/INN); Quarzan (TN) |
(P) unclassified |
| D00717 |
Dicyclomine hydrochloride (JAN/USP); Dicycloverine hydrochloride; Bentyl (TN); Urispas (TN) |
(P) unclassified |
| D00719 |
Hyoscyamine sulfate (USP); Hyoscyamine sulfate dihydrate; Egacene (TN) |
(P) unclassified |
| D00720 |
Mepenzolate bromide (JP18/INN); Cantil (TN) |
(P) unclassified |
| D00721 |
Methanthelinium bromide (INN); Methantheline bromide; Banthine (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP18); Ditropan (TN); Gelnique (TN) |
(P) unclassified |
| D00723 |
Tridihexethyl chloride (BAN); Pathilon (TN) |
(P) unclassified |
| D00762 |
Metyrosine (USP); Metirosine (JAN/INN); Demser (TN) |
(P) unclassified |
| D00774 |
Orphenadrine citrate (USP); Norflex (TN) |
(P) unclassified |
| D00778 |
Benztropine mesylate (USP); Benztropine mesilate (JAN); Cogentin (TN) |
(P) unclassified |
| D00779 |
Biperiden (JAN/USP/INN); Akineton (TN) |
(P) unclassified |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP18); Parlodel (TN) |
(P) Target: DRD2 |
| D00782 |
Procyclidine hydrochloride (USP); Kemadrin (TN) |
(P) unclassified |
| D00784 |
Ropinirole hydrochloride (JAN/USP); Requip (TN) |
(P) Enzyme: CYP1A2 / Target: DRD2 |
| D00787 |
Trihexyphenidyl hydrochloride (JP18/USP); Artane (TN) |
(P) unclassified |
| D00789 |
Chlorpromazine hydrochloride (JP18/USP); Sonazine (TN) |
(P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D00809 |
Amitriptyline hydrochloride (JP18/USP); Elavil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00824 |
Fluvoxamine maleate (JP18/USP); Luvox (TN) |
(P) CYP inhibition: CYP1A2 CYP2D6 |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP18); Benylin DM (TN) |
(P) CYP inhibition: CYP2D6 |
| D00874 |
Moxifloxacin hydrochloride (JAN/USP); Avelox (TN); Vigamox (TN) |
(P) unclassified |
| D00960 |
Anastrozole (JP18/USP/INN); Arimidex (TN) |
(P) CYP inhibition: CYP1A2 |
| D00987 |
Cabergoline (JP18/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) Target: DRD2 |
| D00996 |
Epinephrine hydrochloride (JAN); Adrenalin chloride (TN) |
(CI) unclassified |
| D01002 |
Cyclopentolate hydrochloride (JP18/USP); Cyclogyl (TN) |
(P) unclassified |
| D01003 |
Hexocyclium metilsulfate (INN); Hexocyclium methyl sulfate; Tral (TN) |
(P) unclassified |
| D01004 |
Homatropine hydrobromide (JP18/USP); Isopto homatropine (TN) |
(P) unclassified |
| D01005 |
Isopropamide iodide (JAN/USP/INN); Darbid (TN) |
(P) unclassified |
| D01006 |
Oxyphencyclimine hydrochloride (JAN); Daricon (TN) |
(P) unclassified |
| D01007 |
Propiverine hydrochloride (JP18); Bup-4 (TN); Mictonorm (TN) |
(P) unclassified |
| D01028 |
Ticlopidine hydrochloride (JP18/USP); Ticlid (TN) |
(P) CYP inhibition: CYP1A2 |
| D01051 |
Spiperone (JAN/USAN); Spiropitan (TN) |
(P) Target: DRD2 |
| D01071 |
Hexobarbital (JAN/INN) |
(P) unclassified |
| D01077 |
Methylatropine nitrate (USAN); Atropine methonitrate (JAN/INN); Ekomine (TN) |
(P) unclassified |
| D01103 |
Trospium chloride (JAN/USP/INN); Spasmex (TN); Spasmoplex (TN) |
(P) unclassified |
| D01118 |
Profenamine hydrochloride (JAN); Ethopropazine hydrochloride; Parkin (TN); Parsidol (TN) |
(P) unclassified |
| D01148 |
Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) |
(P) CYP inhibition: CYP2D6 |
| D01153 |
Pazufloxacin (JAN/INN) |
(P) CYP inhibition: CYP1A2 |
| D01164 |
Aripiprazole (JAN/USP/INN); Abilify (TN) |
(P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6 |
| D01165 |
Piperidolate hydrochloride (JAN); Dactil (TN) |
(P) unclassified |
| D01201 |
Tiemonium iodide (JAN/INN); Visceralgine (TN) |
(P) unclassified |
| D01224 |
Phenylpropanolamine hydrochloride (JAN/USP) |
(P) CYP inhibition: CYP1A2 |
| D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) unclassified |
| D01231 |
Piroheptine hydrochloride (JAN); Trimol (TN) |
(P) unclassified |
| D01269 |
Solifenacin succinate (JAN/USAN/INN); Vesicare (TN) |
(P) unclassified |
| D01297 |
Pirenzepine hydrochloride (USAN) |
(P) unclassified |
| D01302 |
Hydralazine hydrochloride (JP18/USP); Apresoline (TN) |
(P) unclassified |
| D01310 |
Secobarbital sodium (JAN/USP); Seconal sodium (TN) |
(P) unclassified |
| D01315 |
Methylbenactyzium bromide (JP18/INN) |
(P) unclassified |
| D01333 |
Urapidil (JP18/INN); Ebrantil (TN) |
(P) CYP inhibition: CYP2D6 |
| D01348 |
Terguride (JAN/INN); Teluron (TN) |
(P) Target: DRD2 |
| D01359 |
Etomidoline (JAN/INN); Smedolin (TN) |
(P) unclassified |
| D01377 |
Prifinium bromide (JAN/INN); Padrin (TN) |
(P) unclassified |
| D01382 |
Metharbital (JAN/INN); Gemonil (TN) |
(P) unclassified |
| D01451 |
Scopolamine butylbromide (JP18); Butylscopolamine bromide; Buscopan (TN) |
(P) unclassified |
| D01462 |
Lisuride maleate (JAN) |
(P) Target: DRD2 |
| D01463 |
Diponium bromide (JAN/INN); Dipenine bromide |
(P) unclassified |
| D01482 |
Pipamperone hydrochloride (JAN) |
(P) Target: DRD2 |
| D01491 |
Butropium bromide (JP18/INN); Coliopan (TN) |
(P) unclassified |
| D01505 |
Talipexole hydrochloride (JAN); Domin (TN) |
(P) Target: DRD2 |
| D01521 |
Pipethanate hydrochloride (JAN); Glymor (TN) |
(P) unclassified |
| D01531 |
Pipemidic acid hydrate (JP18); Karunomazin (TN) |
(P) CYP inhibition: CYP1A2 |
| D01538 |
Valethamate bromide (JAN); Shinmetane (TN) |
(P) unclassified |
| D01600 |
Diphenylpiperidinomethyldioxolan iodide (JAN); Anacolin; Gastrophyllin-A (TN) |
(P) unclassified |
| D01603 |
Bethanidine sulfate (JAN/USAN); Tenathan (TN) |
(P) unclassified |
| D01648 |
Hyoscyamine methylbromide (JAN) |
(P) unclassified |
| D01699 |
Darifenacin hydrobromide (JAN/USAN); Enablex (TN) |
(P) CYP inhibition: CYP2D6 |
| D01740 |
Barbital (JP18/INN); Barbital (TN) |
(P) unclassified |
| D01804 |
Cadralazine (JP18/INN); Cadral (TN) |
(P) unclassified |
| D01815 |
Oxapium iodide (JP18/INN); Espalexan (TN) |
(P) unclassified |
| D01871 |
Methixene hydrochloride (USAN); Metixene hydrochloride (JAN); Methixene hydrochloride hydrete; Trest (TN) |
(P) unclassified |
| D01875 |
Tiquizium bromide (JAN/INN); Thiaton (TN) |
(P) unclassified |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) Target: DRD2 / CYP inhibition: CYP2D6 |
| D01929 |
Tiotropium bromide hydrate (JAN); Tiotropium bromide monohydrate; Spiriva (TN) |
(P) unclassified |
| D01946 |
Oxitropium bromide (JAN/INN); Tersigan (TN) |
(P) unclassified |
| D01976 |
N-Methylscopolamine methylsulfate (JAN); Daipin (TN) |
(P) unclassified |
| D02004 |
Apomorphine hydrochloride (USP); Apomorphine hydrochloride hydrate (JAN); Apokyn (TN); Ixense (TN); Uprima (TN) |
(P) Target: DRD2 |
| D02069 |
Atropine sulfate (JP18/USP); Isopto Atropine (TN) |
(P) unclassified |
| D02070 |
Homatropine methylbromide (USP); Equipin (TN) |
(P) unclassified |
| D02071 |
Scopolamine hydrobromide (USP); Scopolamine hydrobromide hydrate (JP18); Scopolamine hydrobromide trihydrate; Hysco (TN); Isopto hyoscine (TN) |
(P) unclassified |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) CYP inhibition: CYP2D6 |
| D02106 |
Arsenic trioxide (JP18/USAN); Trisenox (TN) |
(P) unclassified |
| D02135 |
Levodopa and benserazide hydrochloride; Madopar (TN) |
(P) unclassified |
| D02149 |
Epinephrine bitartrate (JAN/USP); Asmatane mist (TN); Medihaler-epi (TN) |
(CI) unclassified |
| D02211 |
Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP18); Migranal (TN); Trudhesa (TN) |
(P) unclassified |
| D02212 |
Ipratropium bromide (USP); Ipratropium bromide hydrate (JP18); Atrovent (TN) |
(P) unclassified |
| D02216 |
Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP18); Ciloxan (TN); Cipro (TN); Proquin XR (TN) |
(P) CYP inhibition: CYP1A2 |
| D02237 |
Guanethidine sulfate (USAN) |
(P) unclassified |
| D02246 |
Biperiden hydrochloride (JP18/USP); Tasmolin (TN) |
(P) unclassified |
| D02247 |
Biperiden lactate (JAN/USP); Tasmolin (TN) |
(P) unclassified |
| D02252 |
Amobarbital sodium (JAN/USP); Amytal sodium (TN) |
(P) unclassified |
| D02253 |
Pentobarbital calcium (JP18); Ravona (TN) |
(P) unclassified |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP18); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D02312 |
Methylene blue (USP); Methylthioninium chloride; Methylthioninium chloride proveblue (TN) |
(P) CYP inhibition: CYP1A2 |
| D02362 |
Paroxetine (USP/INN); Paroxetine (TN) |
(P) CYP inhibition: CYP2D6 |
| D02363 |
Ketanserin (USAN/INN) |
(P) Target: HTR2A |
| D02417 |
Flutropium bromide (JAN); Flutropium bromide monohydrate; Flubron (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02535 |
Timepidium bromide hydrate (JP18); Sesden (TN) |
(P) unclassified |
| D02564 |
Pargyline hydrochloride (USAN); Eutonyl (TN) |
(P) unclassified |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) CYP inhibition: CYP2D6 |
| D02599 |
Orphenadrine hydrochloride; Disipal (TN) |
(P) unclassified |
| D02618 |
Butobarbital (BAN); Butethal; Neonal (TN) |
(P) unclassified |
| D02748 |
Peginterferon alfa-2b (USAN/INN); Peginterferon alfa-2b (genetical recombination) (JAN); Pegintron (TN); Sylatron (TN) |
(P) CYP inhibition: CYP1A2 |
| D02775 |
Adrogolide hydrochloride (USAN) |
(P) unclassified |
| D02817 |
Allobarbital (USAN/INN) |
(P) unclassified |
| D02876 |
Alvameline maleate (USAN) |
(P) unclassified |
| D03087 |
Benzetimide hydrochloride (USAN); Dioxatrine (TN) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) Target: DRD2 |
| D03180 |
Butabarbital (USP); Secbutabarbital (BAN) |
(P) unclassified |
| D03182 |
Butalbital (USP/INN); Sandoptal (TN) |
(P) unclassified |
| D03214 |
Aplindore fumarate (USAN) |
(P) Target: DRD2 |
| D03264 |
Mazaticol hydrochloride hydrate (JAN); Mazaticol hydrochloride; Pentona (TN) |
(P) unclassified |
| D03274 |
Chlorpromazine hibenzate (JAN); Contomin (TN) |
(P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D03276 |
Profenamine hibenzate (JAN); Parkin (TN) |
(P) unclassified |
| D03494 |
Ciladopa hydrochloride (USAN); Tremerase (TN) |
(P) Target: DRD2 |
| D03654 |
Darifenacin (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D03664 |
Debrisoquin sulfate (USAN); Declinax (TN) |
(P) CYP inhibition: CYP2D6 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP inhibition: CYP1A2 |
| D03711 |
Dexetimide (USAN/INN); (+)-Benzetimide |
(P) unclassified |
| D03814 |
Atropine methylbromide (JAN) |
(P) unclassified |
| D03824 |
Dihexyverine hydrochloride (USAN) |
(P) unclassified |
| D03891 |
Dopexamine (USAN/INN) |
(P) Target: DRD2 |
| D03892 |
Dopexamine hydrochloride (USAN); Dopacard (TN) |
(P) Target: DRD2 |
| D03994 |
Endralazine mesylate (USAN); Endralazine monomethanesulfonate; Migranal (TN) |
(P) unclassified |
| D04034 |
Chlorpromazine phenolphthalinate (JAN); Wintermin (TN) |
(P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D04052 |
Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) |
(CI,P) Enzyme: CYP1A2 |
| D04057 |
Esoxybutynin chloride (USAN) |
(P) unclassified |
| D04077 |
Eterobarb (USAN/INN); Antilon (TN) |
(P) unclassified |
| D04087 |
Ethybenztropine (USAN); Etybenzatropine (INN); Panolid (TN) |
(P) unclassified |
| D04116 |
Eucatropine hydrochloride (USP XXXII) |
(P) unclassified |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) Enzyme: CYP1A2 / Target: HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D04265 |
Reserpine, hydralazine hydrochloride and hydrochlorothiazide |
(P) unclassified |
| D04266 |
Benzylhydrochlorothiazide, Reserpine and Carbazochrome; Behyd RA (TN) |
(P) unclassified |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) CYP inhibition: CYP2D6 |
| D04382 |
Guanethidine monosulfate (USP); Guanethidine sulfate (JP18); Ismelin (TN) |
(P) unclassified |
| D04386 |
Guanoclor sulfate (USAN); Vatensol (TN) |
(P) unclassified |
| D04398 |
Guanoxabenz (USAN/INN) |
(P) unclassified |
| D04399 |
Guanoxan sulfate (USAN); Envacar (TN) |
(P) unclassified |
| D04458 |
Hydralazine polistirex (USAN) |
(P) unclassified |
| D04479 |
Hyoscyamine hydrobromide (USP) |
(P) unclassified |
| D04488 |
Ibopamine (USAN/INN) |
(P) Target: DRD2 |
| D04531 |
Indoramin (USAN/INN) |
(P) unclassified |
| D04532 |
Indoramin hydrochloride (USAN) |
(P) unclassified |
| D04693 |
Lergotrile (USAN/INN) |
(P) Target: DRD2 |
| D04694 |
Lergotrile mesylate (USAN) |
(P) Target: DRD2 |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04813 |
Lidocaine hydrochloride and epinephrine bitartrate; Lidocaine hydrochloride and adrenaline bitartrate; Ora (TN); Lidosite (TN) |
(P) Enzyme: CYP1A2 |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(P) Target: DRD2 HTR2A |
| D04868 |
Mebeverine hydrochloride (USAN) |
(P) unclassified |
| D04985 |
Methohexital (USP/INN) |
(P) unclassified |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) CYP inhibition: CYP1A2 |
| D05087 |
Moxonidine (USAN/INN); Cynt (TN) |
(P) unclassified |
| D05276 |
Pirenzepine hydrochloride hydrate (JP18); Gastrozepin (TN) |
(P) unclassified |
| D05374 |
Paroxetine hydrochloride (USP); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D05375 |
Paroxetine mesylate (USAN); Brisdelle (TN); Pexeva (TN) |
(P) CYP inhibition: CYP2D6 |
| D05382 |
Pazufloxacin mesilate (JP18); Pazufloxacin methanesulfonate; Pasil (TN) |
(P) CYP inhibition: CYP1A2 |
| D05461 |
Enoxacin hydrate (JP18) |
(P) CYP inhibition: CYP1A2 |
| D05466 |
Phenylpropanolamine polistirex (USAN) |
(P) CYP inhibition: CYP1A2 |
| D05482 |
Pinacidil (USAN); Pinacidil hydrate; Pindac (TN) |
(P) unclassified |
| D05575 |
Pramipexole (USAN/INN) |
(P) Target: DRD2 |
| D05677 |
Quinelorane hydrochloride (USAN) |
(P) Target: DRD2 |
| D05682 |
Quinpirole hydrochloride (USAN) |
(P) Target: DRD2 |
| D05705 |
Rauwolfia serpentina (USP); Rauwolfia extract; Himolfia (TN) |
(P) unclassified |
| D05768 |
Rotigotine (JAN/USAN/INN); Neupro (TN) |
(P) Target: DRD2 |
| D05832 |
Sibenadet hydrochloride (USAN); Viozan (TN) |
(P) Target: DRD2 |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D06106 |
Thiamylal |
(P) unclassified |
| D06234 |
Trimazosin hydrochloride (USAN); Trimazosin hydrochloride monohydrate |
(P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) unclassified |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN) |
(P) unclassified |
| D06887 |
Talbutal (INN); Lotusate (TN) |
(P) unclassified |
| D07076 |
Camylofin (INN); Anafortan (TN) |
(P) unclassified |
| D07077 |
Ambrisentan (JAN/INN); Letairis (TN); Volibris (TN) |
(P) unclassified |
| D07099 |
Cimetropium bromide (JAN/INN); Alginor (TN) |
(P) unclassified |
| D07166 |
Methoserpidine (INN) |
(P) unclassified |
| D07167 |
Bietaserpine (prop.INN) |
(P) unclassified |
| D07168 |
Tolonidine (INN) |
(P) unclassified |
| D07169 |
Guanazodine (INN) |
(P) unclassified |
| D07170 |
Dihydralazine (INN) |
(P) unclassified |
| D07171 |
Sitaxentan (USAN/INN) |
(P) unclassified |
| D07217 |
Quinagolide (INN/BAN) |
(P) Target: DRD2 |
| D07226 |
Fesoterodine (INN) |
(P) CYP inhibition: CYP2D6 |
| D07298 |
Barbexaclone (INN); Maliasin (TN) |
(P) unclassified |
| D07301 |
Phenglutarimide (INN) |
(P) unclassified |
| D07302 |
Bornaprine (INN) |
(P) unclassified |
| D07303 |
Tropatepine (INN) |
(P) unclassified |
| D07305 |
Piribedil (INN); Trivastal (TN) |
(P) Target: DRD2 |
| D07321 |
Vinylbital (INN); Vinylbitone |
(P) unclassified |
| D07322 |
Vinbarbital (INN) |
(P) unclassified |
| D07323 |
Cyclobarbital (INN); Ciclobarbital (TN) |
(P) unclassified |
| D07324 |
Proxibarbal (INN); Centralgol (TN) |
(P) unclassified |
| D07406 |
Pimethixene (INN); Calmixene (TN) |
(P) unclassified |
| D07460 |
Apomorphine (BAN); Uprima (TN) |
(P) Target: DRD2 |
| D07505 |
Latanoprost and timolol maleate; Xalacom (TN) |
(P) unclassified |
| D07511 |
Benzatropine (INN); Benztropine |
(P) unclassified |
| D07513 |
Benzetimide (INN); Spasmental [veterinary] (TN) |
(P) unclassified |
| D07538 |
Bosentan (INN) |
(P) unclassified |
| D07564 |
Allopurinol sodium; Aloprim (TN) |
(P) CYP inhibition: CYP1A2 |
| D07702 |
Ciprofloxacin lactate; Ciproxin (TN) |
(P) CYP inhibition: CYP1A2 |
| D07757 |
Cyclobarbital calcium (BAN); Phanodorn calcium (TN) |
(P) unclassified |
| D07759 |
Cyclopentolate (INN); Bell Pentolate (TN) |
(P) unclassified |
| D07804 |
Dexetimide hydrochloride; Tremblex (TN) |
(P) unclassified |
| D07820 |
Dicycloverine (INN); Dicyclomine; Dicymine (TN) |
(P) unclassified |
| D07821 |
Dihexyverine (INN) |
(P) unclassified |
| D07830 |
Dihydralazine sulfate; Dihydralazine hydrogen sulfate; Nepresol (TN) |
(P) unclassified |
| D07837 |
Dihydroergotamine (INN); Neomigran (TN) |
(P) unclassified |
| D07838 |
Dihydroergotamine tartrate; Divegal (TN) |
(P) unclassified |
| D07870 |
Dopamine (INN); Medopa (TN) |
(P) Target: DRD2 |
| D07874 |
Doxazosin (INN); Cardura XL (TN) |
(P) unclassified |
| D07906 |
Ergotamine (INN) |
(P) Target: HTR1A |
| D07946 |
Fenoldopam (INN); Carlacor (TN) |
(P) unclassified |
| D07951 |
Fentonium bromide (INN); Ulcesium (TN) |
(P) unclassified |
| D07984 |
Fluvoxamine (INN) |
(P) CYP inhibition: CYP2D6 CYP1A2 |
| D08030 |
Guanethidine (INN) |
(P) unclassified |
| D08031 |
Guanfacine (INN); Estulic (TN) |
(P) unclassified |
| D08044 |
Hydralazine (INN); Hidral (TN) |
(P) unclassified |
| D08057 |
Ibopamine hydrochloride; Scandine (TN) |
(P) Target: DRD2 |
| D08099 |
Ketanserin tartrate; Sufrexal (TN) |
(P) Target: HTR2A |
| D08132 |
Lisuride (INN) |
(P) Target: DRD2 |
| D08157 |
Mazaticol (INN) |
(P) unclassified |
| D08160 |
Mebeverine (INN); Arluy (TN) |
(P) unclassified |
| D08194 |
Deserpidine (INN); Halmonyl (TN) |
(P) unclassified |
| D08205 |
Methyldopa (INN); Aldomet (TN) |
(P) unclassified |
| D08209 |
Metixene (INN) |
(P) unclassified |
| D08212 |
Trimazosin (INN) |
(P) unclassified |
| D08217 |
Mibefradil (INN) |
(P) CYP inhibition: CYP1A2 |
| D08254 |
Endralazine (INN) |
(P) unclassified |
| D08287 |
Norfloxacin nicotinate; Quinabic soluble powder (TN) [veterinary] |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2 |
| D08305 |
Orphenadrine (INN); Mialgin (TN) |
(P) unclassified |
| D08325 |
Oxyphencyclimine (INN) |
(P) unclassified |
| D08339 |
Pergolide (INN); Permax (TN) |
(P) Target: DRD2 |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08368 |
Phenylpropanolamine (INN); Fansia (TN) |
(P) CYP inhibition: CYP1A2 |
| D08379 |
Pipemidic acid (INN); Nuril (TN) |
(P) CYP inhibition: CYP1A2 |
| D08382 |
Piperidolate (INN) |
(P) unclassified |
| D08384 |
Pipethanate (INN); Piperilate |
(P) unclassified |
| D08389 |
Pirenzepine (USAN/INN) |
(P) unclassified |
| D08395 |
Piroheptine (INN) |
(P) unclassified |
| D08411 |
Prazosin (INN); Minipress (TN) |
(P) unclassified |
| D08425 |
Procyclidine (INN) |
(P) unclassified |
| D08426 |
Profenamine (INN) |
(P) unclassified |
| D08441 |
Propiverine (INN) |
(P) unclassified |
| D08453 |
Pargyline (INN) |
(P) unclassified |
| D08457 |
Quinagolide hydrochloride (BAN); Norprolac (TN) |
(P) Target: DRD2 |
| D08482 |
Rilmenidine (INN); Hyperium (TN) |
(P) unclassified |
| D08489 |
Ropinirole (USAN/INN); Ropitor (TN) |
(P) Enzyme: CYP1A2 / Target: DRD2 |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP18); Cosopt (TN) |
(P) CYP inhibition: CYP2D6 |
| D08517 |
Sitaxentan sodium (USAN); Thelin (TN) |
(P) unclassified |
| D08522 |
Solifenacin (INN) |
(P) unclassified |
| D08558 |
Talipexole (INN) |
(P) Target: DRD2 |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) Enzyme: CYP1A2 / CYP inhibition: CYP2D6 |
| D08594 |
Ticlopidine (INN); Ticlopidin-Puren (TN) |
(P) CYP inhibition: CYP1A2 |
| D08595 |
Tiemonium methylsulfate; Visceralgine (TN) |
(P) unclassified |
| D08638 |
Trihexyphenidyl (INN); Apo-trihex (TN) |
(P) unclassified |
| D08653 |
Tropatepine hydrochloride; Lepticur (TN) |
(P) unclassified |
| D08662 |
Urapidil hydrochloride; Ebrantil (TN) |
(P) CYP inhibition: CYP2D6 |
| D08837 |
Aclidinium bromide (JAN/USAN/INN); Tudorza pressair (TN); Eklira genuair (TN) |
(P) unclassified |
| D08838 |
Acotiamide hydrochloride (USAN); Acotiamide hydrochloride hydrate (JAN) |
(P) unclassified |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) CYP inhibition: CYP2D6 |
| D09402 |
Darotropium bromide (USAN/INN) |
(P) unclassified |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09815 |
Travoprost and timolol maleate; Duotrav (TN) |
(P) unclassified |
| D09819 |
Chlorpromazine tannate (JAN) |
(P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6 |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) CYP inhibition: CYP2D6 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP inhibition: CYP1A2 |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(P) unclassified |
| D10180 |
Umeclidinium (USAN) |
(P) CYP inhibition: CYP2D6 |
| D10181 |
Umeclidinium bromide (JAN/USAN); Incruse ellipta (TN) |
(P) CYP inhibition: CYP2D6 |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) Target: HTR1A / CYP inhibition: CYP2D6 |
| D10267 |
Methyldopa and hydrochlorothiazide; Methyldopa and hydrochlorothiazide (TN) |
(P) unclassified |
| D10293 |
Carbidopa, levodopa and entacapone; Stalevo (TN) |
(P) unclassified |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP inhibition: CYP2D6 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6 |
| D10537 |
Methylthioninium chloride hydrate (JAN); Methylene blue (TN) |
(P) CYP inhibition: CYP1A2 |
| D10569 |
Tafluprost and timolol maleate; Tapcom (TN) |
(P) unclassified |
| D10591 |
Clonidine and chlorthalidone; Clorpres (TN) |
(P) unclassified |
| D10793 |
Sodium picosulfate hydrate, magnesium oxide and citric acid, anhydrous; Picoprep (TN); Prepopik (TN); Clenpiq (TN) |
(P) unclassified |
| D10822 |
Ciprofloxacin hydrate (JAN); Ciprofloxacin hemiheptahydrate |
(P) CYP inhibition: CYP1A2 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) unclassified |
| D10938 |
Glycopyrronium (USAN) |
(P) unclassified |
| D10939 |
Glycopyrronium tosylate (USAN); Glycopyrronium tosilate hydrate (JAN); Glycopyrronium tosylate monohydrate; Qbrexza (TN); Rapifort (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) unclassified |
| D11027 |
Ropeginterferon alfa-2b (INN); Ropeginterferon alfa-2b (genetical recombination) (JAN); Ropeginterferon alfa-2b-njft; Besremi (TN) |
(P) unclassified |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) CYP inhibition: CYP2D6 |
| D11441 |
Aprocitentan (USAN/INN); Tryvio (TN) |
(P) unclassified |
| D11708 |
Givosiran sodium (JAN); Givlaari (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) CYP inhibition: CYP1A2 |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
| D12494 |
Foslevodopa and foscarbidopa; Vyalev (TN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12766 |
Razpipadon (USAN/INN) |
(P) unclassified |
